Sinocare Showcases Integrated Smart Health Management Ecosystem at EASD 2026

From September 28 to October 2, 2026, the 62nd Annual Meeting of the European Association for the Study of Diabetes (EASD) was held in Milan, Italy. As a major international academic event in diabetes and metabolic health, this year’s meeting focused on emerging approaches to the integrated management of multisystem comorbidities, including cardiovascular-kidney-metabolic (CKM) syndrome.

In recent years, the CKM concept has gained increasing attention, moving beyond traditional disease-specific approaches toward integrated management of multisystem comorbidities. In response to this evolving trend, Sinocare showcased a smart health management ecosystem spanning three key settings—home, primary care and professional healthcare. By integrating biosensing with healthcare, Sinocare is developing digital approaches to diabetes and chronic disease management, offering innovative products and smart healthcare solutions covering prevention, monitoring and long-term management for users worldwide.

Smart Solutions for Home and Primary Care

Across home and primary care settings, Sinocare’s solutions focus on accuracy, simplicity and accessibility, helping integrate health management into everyday life.

For home care, the Safe AQ max II Blood Glucose Monitoring System provides blood glucose results in as little as five seconds and supports Bluetooth synchronization as well as pre- and post-meal tagging. The KUG-11 Glucose, Uric Acid & Ketone Meter combines three metabolic tests in one device, while the GV-100 Veterinary Blood Glucose Monitoring System supports diabetes care for pets at home.

In primary care, the iCARE-1300 Portable Automatic Multifunction Analyzer requires only a small blood sample and can test more than 100 parameters—including blood glucose, a four-parameter lipid panel, glycated hemoglobin (HbA1c) and renal function—in approximately 3 to 15 minutes. Through its Health Station model, Sinocare is also helping pharmacies develop into community health access points with chronic disease screening and risk assessment capabilities. During EASD 2026, Sinocare also offered on-site testing with the iCARE-1300, attracting substantial participation from conference attendees.

Connecting Clinical Testing with Patient Management

To address challenges such as fragmented devices and data silos in professional healthcare settings, Sinocare is connecting diagnostic data with digital patient management through its hospital-based solutions.

The AGEscan Advanced Glycation End Products Fluorescence Detector enables non-invasive detection of advanced glycation end products (AGEs) without blood sampling and can complete a measurement in approximately six seconds, supporting early risk screening.

In addition, Sinocare’s Diabetes Digital Management System, powered by the Safe AQ 8000 Glucose, Uric Acid & Ketone Analyzer, integrates with hospital information systems (HIS) and consolidates data from blood glucose meters and continuous glucose monitoring (CGM) systems. It supports multi-terminal access and intelligent alerts, as well as rapid bedside testing and more refined patient monitoring.

From non-invasive screening to bedside testing, these solutions aim to make diagnostic data continuously available and actionable throughout the clinical workflow.

Exploring the Future of Smart Health

Sinocare remains committed to its mission of providing innovative, high-quality products and services for people living with diabetes and related chronic diseases worldwide, helping them improve their quality of life.

As glucose signals become increasingly integrated with multimodal data such as sleep, respiration and physical activity, iCan Health is evolving from a glucose management tool toward a gateway to broader metabolic health management.

Looking ahead, Sinocare will continue to explore the integration of AI agents, diabetes and chronic disease expertise, and long-term behavioral management, working with partners worldwide to advance smart health and bring emerging technologies into meaningful, everyday healthcare.